Abstract:A novel biodegradable amphiphilic diblock copolymer methoxy poly(ethylene glycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε-caprolactone) (mPEG-b-P(CL-co-HCL)) bearing pendant hydroxyl groups on the PCL block was prepared. The hydroxyl groups were formed through the reduction of ketones by sodium borohydride without protection and deprotection. The obtained polymers were well characterized by (1)H NMR, Fourier transform infrared (FT-IR), gel permeation chromatography (GPC), differential scanning calorimetry (DSC), X-ray diffraction (XRD), and contact angle measurement. mPEG-b-P(CL-co-HCL) could self-assemble into stable nanoparticles (NPs) with critical micellar concentrations (CMC) of 6.3 × 10(-4) ∼ 8.1 × 10(-4) mg/mL. The NPs prepared from mPEG-b-P(CL-co-HCL) were spherical in shape with diameters about 100 to 140 nm. The hydrophobic doxorubicin (DOX) was chosen as a drug model and successfully encapsulated into the NPs. The encapsulation efficiency and release kinetics of DOX were investigated. The results indicated that the introduction of hydroxyl groups onto the core-forming block could decrease the hydrophobicity of copolymers, thus improving the storage stability of NPs in aqueous solution. Moreover, higher loading capacity and slower in vitro release of DOX were observed, which was due to the hydrogen-bonding formation between DOX and hydroxyl groups. Meanwhile, the MTT assay demonstrated that the blank NPs were biocompatible to HepG2 cell,s while free DOX and DOX-loaded NPs showed significant cytotoxicity against the cells. Moreover, Compared to the free DOX, the DOX-loaded NPs were more efficiently internalized by HepG2 cells. In sum, the introduction of hydroxyl groups on the polyester block in mPEG-b-P(CL-co-HCL) exhibited great potentials for modifications in the stability, drug solubilization, and release properties of NPs.

Preparation and Characterization of Oridonin-loaded Poly (caprolactone)-Poly (ethylene oxide)-Poly (caprolactone) Copolymer Nanoparticles

Oridonin-loaded poly(ε-caprolactone)–poly(ethylene oxide)–poly(ε-caprolactone) copolymer nanoparticles: Preparation, characterization, and antitumor activity on mice with transplanted hepatoma

Preparation And Characteristics Of Oridonin-Loaded Nanostructured Lipid Carriers As A Controlled-Release Delivery System

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers

Preparation and Biological Characterization of Hollow Magnetic Fe3O4@C Nanoparticles As Drug Carriers with High Drug Loading Capability, Ph-Control Drug Release and MRI Properties

Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- Caprolactone) Bearing Pendant Hydroxyl Groups As Nanocarriers for Doxorubicin Delivery.

Preparation and characterization of N-phthaloyl-chitosan-g-(PEO–PLA–PEO) as a potential drug carrier

In Vivo Studies On The Oridonin-Loaded Nanostructured Lipid Carriers

Preparation and Characterization of Galactosylated Bovine Serum Albumin Nanoparticles for Liver-Targeted Delivery of Oridonin.

Preparation and Characterization of Biodegradable Nanoparticles from Methoxy Poly(ethylene Glycol)-Poly(d,l-lactide)block Copolymers As Novel Drug Carriers

Poly(ether-ester Anhydride)-Based Amphiphilic Block Copolymer Nanoparticle As Delivery Devices for Paclitaxel

Colloidal Characteristics of Poly(L-Lactic Acid)-b-Poly (ε-Caprolactone) Block Copolymer-Based Nanoparticles Obtained by an Emulsification/Evaporation Method

Galactosylated Chitosan Nanoparticles for Hepatocyte-Targeted Delivery of Oridonin

Preparation, Characterization, and Drug Release Behaviors of Drug-Loaded E-Caprolactone/l-lactide Copolymer Nanoparticles

Photo-crosslinked Poly(ethylene Glycol)-B-poly(ϵ-caprolactone) Nanoparticles for Controllable Paclitaxel Release

Preparation, Characterization, and Drug Release Behaviors of Drug Nimodipine‐loaded Poly(ε‐caprolactone)‐poly(ethylene Oxide)‐poly(ε‐caprolactone) Amphiphilic Triblock Copolymer Micelles

Novel nanoparticles of cisplatin:Preparation and study of properties

Preparation and Characterization of Modified Lipid Nanoparticles for Doxorubicin Controlled Release.

Preparation, Characterization And Drug Release Behavior Of 5-Fluorouracil Loaded Carboxylic Poly(Epsilon-Caprolactone) Nanoparticles

Synthesis, characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates.

Exploring the Effect of Drug Loading on the Biological Fate of Polymer-Coated Solid Nanoparticles